|
|||||
|
|
Risk assessment in drug development for symptomatic indications: a framework for the prospective exclusion of unacceptable cardiovascular risk |
|
| Authors: | Brass Eric P Lewis Roger J Lipicky Raymond Murphy James Hiatt William R |
| Affiliation: | Department of Medicine, Section of Vascular Medicine, University of Colorado Health Sciences Center, Colorado Prevention Center, and National Jewish Medical and Research Center, Denver, 80203, USA. |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |